METHODS: In this multicenter, randomized, double-blind, placebo-controlled trial, we assigned 251 patients to receive 50 mg of intravenous hydrocortisone and 248 patients to receive placebo every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results